top of page

Tirzepatide: An Alternative or a Complement to TRT

Tirzepatide should NOT be seen as dismissing TRT. Rather, it offers an alternative for overweight men—especially those whose low testosterone is tied to excess weight and metabolism.

​

By reducing excess fat, tirzepatide lowers the conversion of natural testosterone into estrogen and helps restore the body’s ability to maintain healthy testosterone levels.

​

For men already on TRT, this makes tirzepatide a powerful complement used in conjunction with TRT, supporting weight loss and enhancing hormonal balance.

Medical Disclaimer: This content is for informational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a physician  or qualified health care provider to discuss whether treatments like GLP-1s or TRT are right for you.

​

Medially authored by Joshua Silva, MD, medical director of Potere Health MD. Updated 07/07/2026.

Medical diagram by Potere Health MD illustrating how Tirzepatide injections lead to significant body fat reduction in men, which decreases aromatase enzyme activity and results in a natural increase in testosterone levels.

Common Questions about Tirzpepatide & Testosterone Replacement Therapy

  • Tirzepatide may be appropriate for overweight men whose low testosterone symptoms occur alongside abdominal weight gain, insulin resistance, food cravings, or difficulty losing weight. It may be especially relevant when excess fat is contributing to higher estrogen conversion. Men with confirmed primary hypogonadism may still need TRT.

  • Yes, tirzepatide may help increase testosterone in some men, especially when low testosterone is related to excess weight, insulin resistance, or abdominal fat. By supporting weight loss and reducing waist circumference, tirzepatide may lower estrogen conversion and help the body maintain healthier natural testosterone levels.

  • Yes, tirzepatide and TRT can be used together when medically appropriate. For men already on testosterone therapy, tirzepatide may support weight loss, reduce abdominal fat, and improve hormone balance by lowering the amount of testosterone converted into estrogen through fat tissue.

  • Belly fat can lower testosterone because fat tissue contains aromatase, an enzyme that converts testosterone into estrogen. The more excess abdominal fat a man carries, the more this conversion may occur. Losing fat may help testosterone stay available as testosterone instead of being converted into estrogen.

  • For weight loss, tirzepatide is usually more directly effective than TRT because it targets appetite, cravings, blood sugar, and metabolism. TRT may help men with confirmed testosterone deficiency, but it is not primarily a weight-loss medication. Some men benefit most from addressing both weight and hormone health together.

What the 2025 Tirzepatide/TRT Study Showed

A 2025 clinical pilot study (La Vignera et al., Reproductive Biology and Endocrinology) compared overweight men treated with tirzepatide to those receiving testosterone therapy (TRT). Over 8 weeks, the study tracked changes in weight, waist size, and hormone levels.

 

The results confirmed a clear link between excess body fat and hormonal imbalance in men.

Outcome
Group A – Tirzepatide
Group – TRT
Total Weight Loss
↓ 8.1%
↓ 3.0%
Waist Circumference
↓ 8.2%
↓ 1.8%
Lean Body Mass
↑ 17.9%
↑ 10.5%
Testosterone Levels
↑ 128.5%
↑ 46.2%
Estrogen Levels
↓ 60.0%
↑ 21.2%

Values come from 225 study results, La Vignera et al., Reproductive Biology and Endocrinology

Group A – Tirzepatide + Lifestyle

  • Medication & Dose: Weekly tirzepatide injections (2.5 mg in the first month, increased to 5 mg the following month).

  • Results after 8 weeks:

    • Body weight: ↓ 8.1%

    • Waist circumference: ↓ 8.2%

    • Testosterone: ↑ 128.5% (more than doubled)

    • Estrogen: ↓ 60.8%

Group B – Testosterone (TRT) + Lifestyle

  • Medication Used: Transdermal testosterone gel (AndroGel® 1.62%)

    • Starting Dose: 23 mg/day, applied to the upper arms/shoulders for the first 14 days.

    • Adjustment: After 14 days, the dose was titrated according to the manufacturer’s guidelines (FDA label) to bring blood testosterone into the normal male range (up to a max of 81 mg/day).

  • Results after 8 weeks:

    • Body weight: ↓ 3.0%

    • Waist circumference: ↓ 1.8%

    • Testosterone: ↑ 46.2%

    • Estrogen: ↑ 21.2%

What Do These Findings Mean?

The exciting part of this study isn’t that tirzepatide will help you achieve higher testosterone levels than TRT. If you increase the dose of TRT enough, your testosterone will rise indefinitely.

​

What makes these findings important is that they highlight how weight and metabolism affect hormone imbalance in men:

1. The Effect of Fat (Adipose Tissue) on Testosterone Levels

Excess body fat—especially abdominal fat—acts almost like a hormonal organ of its own. Fat tissue produces an enzyme called aromatase, which converts testosterone into estrogen.The more fat you carry, the more aromatization occurs, which lowers available testosterone and raises estrogen. International Journal of Endocrinology (2012),  Journal of Nutrition, Health & Aging (2016)

2. Why Supplemental Testosterone (TRT) Alone May Increase Estrogen

When men with excess fat use TRT, testosterone levels do rise—but a portion of that testosterone is rapidly converted to estrogen by aromatase in fat tissue. This can lead to unwanted side effects of higher estrogen in men, such as fluid retention, breast tissue enlargement (gynecomastia), and decreased testicular size. The study showed exactly this: TRT raised testosterone but also increased estrogen by ~21%. Journal of Clinical Endocrinology & Metabolism (2010)

3. Why Losing Fat Improves Male Hormone Levels

Tirzepatide led to significant fat and waist reduction. Less fat means less aromatization, which means more testosterone stays as testosterone and less is converted to estrogen. The result is a natural rise in testosterone and a fall in estrogen—a healthier hormonal balance without simply pushing testosterone levels artificially higher.

Potere Health MD clinical diagram illustrating how abdominal adipose tissue uses the aromatase enzyme to convert testosterone into estrogen, listing adverse male effects like gynecomastia, fluid retention, and decreased testicular size.

How Belly Fat Lowers Testosterone and Raises Estrogen in Men: Aromatase Mechanism and Adverse Effects

Additional Benefits of Tirzepatide Beyond Hormonal Balance 

Tirzepatide mimics two naturally occurring hormones — GLP-1 and GIP — that work together to support healthy metabolism.


In the brain, these hormones help regulate appetite and reduce food cravings, leading to effective and sustained weight loss.

​

But their benefits don’t stop there. Tirzepatide also exerts its effects throughout the body, providing: 

​

​

Taken together, these benefits show that tirzepatide is more than a weight-loss medication—it also helps protect your metabolism, heart, liver, kidneys, and sleep health.

About the Author


Dr. Joshua Silva, MD, is a licensed physician and Medical Director of Potere Health MD. He earned his medical degree from the University of Hawaiʻi John A. Burns School of Medicine and completed residency training in Occupational and Environmental Medicine at the University of Utah, where he also earned a master’s degree in Occupational Health. He later completed a Master of Business Administration with an emphasis in health care administration at Ohio University.
 
Dr. Silva specializes in evidence-based weight management, including GLP-1 and GIP therapies like tirzepatide to improve metabolic and hormonal health.  He provides in-person and virtual care for patients in Salt Lake City, St. George, and Cedar City, Utah.

Source List

1. Tirzepatide vs. TRT (Clinical Pilot Study) La Vignera S, Cannarella R, Garofalo V, et al. Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study. Reprod Biol Endocrinol. 2025;23:92. doi:10.1186/s12958-025-01425-9
 

2. Adipose Tissue and Androgens Caprio M, Infante M, Morviducci L, et al. Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol. 2012;2012:789653. doi:10.1155/2012/789653
 

3. Testosterone Conversion to Estrogen (Aromatase) Lakshman KM, Kaplan B, Travison TG, et al. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. 2010;95(8):3955-3964. doi:10.1210/jc.2010-0102
 

4. Blood Sugar Control (SURPASS-2) Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503-515. doi:10.1056/NEJMoa2107519
 

5. Lipid Profile & Cholesterol Wilson JM, Lin Y, Luo Z, et al. The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves lipid profile in patients with type 2 diabetes. Diabetes Obes Metab. 2023. doi:10.1111/dom.15272
 

6. Liver Health (SYNERGY-NASH) Loomba R, Hartman ML, Lawitz EJ, et al. Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis. N Engl J Med. 2024;391(4):299-310. doi:10.1056/NEJMoa2401943
 

7. Blood Pressure Reduction (SURMOUNT-1) Krumholz HM, de Lemos JA, Sattar N, et al. Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial. Heart. 2024;110(19):1165-1172. doi:10.1136/heartjnl-2024-324170
 

8. Kidney Protection (SURPASS-4) Heerspink HJL, Sattar N, Pavo I, et al. Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial. Lancet Diabetes Endocrinol. 2022;10(11):774-785. doi:10.1016/S2213-8587(22)00243-1
 

9. Heart Failure (SUMMIT Trial) Packer M, Zile MR, Kramer CM, et al. Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med. 2024. doi:10.1056/NEJMoa2410027

​

10. Heart Health (MACE) JAMA Netw Open. 2024. (Cardiovascular Outcomes of Tirzepatide). doi:10.1001/jamanetworkopen.2024.2822209 (Note: Publisher firewall limits full author extraction, but this is the primary citation path).
 

 

11. Inflammation (Macrophage Targeting) Xia Y, et al. Tirzepatide's role in targeting adipose tissue macrophages and metabolic inflammation. Pharmacol Res. 2024. doi:10.1016/j.phrs.2024.107380

bottom of page